Nie D, Wang X, Sun M, Feng Z, et al. The primary site of head and neck squamous cell carcinoma predicts survival benefits of EGFR inhibitors: a systematic review and meta-analysis. Radiother Oncol 2021 Feb 12. pii: S0167-8140(21)06047.
PMID: 33587969